BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20095789)

  • 1. Inhibitory effects of flavonoids on molybdenum hydroxylases activity.
    Rashidi MR; Nazemiyeh H
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):133-52. PubMed ID: 20095789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase towards substituted benzaldehydes.
    Panoutsopoulos GI; Beedham C
    Acta Biochim Pol; 2004; 51(3):649-63. PubMed ID: 15448727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molybdenum hydroxylase super family shows circadian activity fluctuation in mice liver: emphasis on aldehyde hydroxylase and xanthine oxidase.
    Al-Abbasi FA; Al-Sieni AI
    Pak J Pharm Sci; 2010 Oct; 23(4):359-62. PubMed ID: 20884446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Hydroxyguanidine compound 1-(3,4-dimethoxy- 2-chlorobenzylideneamino)-3-hydroxyguanidine inhibits the xanthine oxidase mediated generation of superoxide radical.
    Dambrova M; Baumane L; Kiuru A; Kalvinsh I; Wikberg JE
    Arch Biochem Biophys; 2000 May; 377(1):101-8. PubMed ID: 10775447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and pathophysiologic role of molybdenum-containing enzymes.
    Moriwaki Y; Yamamoto T; Higashino K
    Histol Histopathol; 1997 Apr; 12(2):513-24. PubMed ID: 9151140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase.
    Torres RA; Korzekwa KR; McMasters DR; Fandozzi CM; Jones JP
    J Med Chem; 2007 Sep; 50(19):4642-7. PubMed ID: 17718551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
    Cos P; Ying L; Calomme M; Hu JP; Cimanga K; Van Poel B; Pieters L; Vlietinck AJ; Vanden Berghe D
    J Nat Prod; 1998 Jan; 61(1):71-6. PubMed ID: 9461655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-metabolizing ability of molybdenum hydroxylases.
    Kitamura S; Sugihara K; Ohta S
    Drug Metab Pharmacokinet; 2006 Apr; 21(2):83-98. PubMed ID: 16702728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of aldehyde oxidase, xanthine oxidase, and aldehyde dehydrogenase on the oxidation of aromatic aldehydes.
    Panoutsopoulos GI; Kouretas D; Beedham C
    Chem Res Toxicol; 2004 Oct; 17(10):1368-76. PubMed ID: 15487898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence favoring molybdenum-carbon bond formation in xanthine oxidase action: 17Q- and 13C-ENDOR and kinetic studies.
    Howes BD; Bray RC; Richards RL; Turner NA; Bennett B; Lowe DJ
    Biochemistry; 1996 Feb; 35(5):1432-43. PubMed ID: 8634273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative EPR and redox studies of three prokaryotic enzymes of the xanthine oxidase family: quinoline 2-oxidoreductase, quinaldine 4-oxidase, and isoquinoline 1-oxidoreductase.
    Canne C; Stephan I; Finsterbusch J; Lingens F; Kappl R; Fetzner S; Hüttermann J
    Biochemistry; 1997 Aug; 36(32):9780-90. PubMed ID: 9245410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of flavonoids on aldehyde oxidase activity.
    Pirouzpanah S; Hanaee J; Razavieh SV; Rashidi MR
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):14-21. PubMed ID: 18608746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of molybdenum hydroxylases in reductive metabolism of nitro polycyclic aromatic hydrocarbons in mammalian skin.
    Ueda O; Sugihara K; Ohta S; Kitamura S
    Drug Metab Dispos; 2005 Sep; 33(9):1312-8. PubMed ID: 15932950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAD-dependent enzymes involved in the metabolic oxidation of xenobiotics.
    Strolin Benedetti M
    Ann Pharm Fr; 2011 Jan; 69(1):45-52. PubMed ID: 21296217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inhibition of human liver aldehyde oxidase by raloxifene.
    Obach RS
    Drug Metab Dispos; 2004 Jan; 32(1):89-97. PubMed ID: 14709625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro study of 6-mercaptopurine oxidation catalysed by aldehyde oxidase and xanthine oxidase.
    Rashidi MR; Beedham C; Smith JS; Davaran S
    Drug Metab Pharmacokinet; 2007 Aug; 22(4):299-306. PubMed ID: 17827784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel ring oxidation of 4- or 5-substituted 2H-oxazole to corresponding 2-oxazolone catalyzed by cytosolic aldehyde oxidase.
    Arora VK; Philip T; Huang S; Shu YZ
    Drug Metab Dispos; 2012 Sep; 40(9):1668-76. PubMed ID: 22621803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site: roles of active site residues in binding and activation of purine substrate.
    Yamaguchi Y; Matsumura T; Ichida K; Okamoto K; Nishino T
    J Biochem; 2007 Apr; 141(4):513-24. PubMed ID: 17301077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic oxidation of 2-phenylethylamine to phenylacetic acid and 2-phenylethanol with special reference to the metabolism of its intermediate phenylacetaldehyde.
    Panoutsopoulos GI; Kouretas D; Gounaris EG; Beedham C
    Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):273-9. PubMed ID: 15569272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of polyphenolic crude extracts as scavengers of superoxide radicals and inhibitors of xanthine oxidase.
    Costantino L; Albasini A; Rastelli G; Benvenuti S
    Planta Med; 1992 Aug; 58(4):342-4. PubMed ID: 1332092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.